Avital Lev
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
-
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Cancer therapeutics and mechanisms 3
- Epigenetics and DNA Methylation 3
- Cell death mechanisms and regulation 3
- Oncology 10
- Cancer-related Molecular Pathways 5
- Cancer Cells and Metastasis 3
- Co-authors
- Wafik S. El‐Deiry (19 shared papers)David T. Dicker (15 shared papers)Amriti R. Lulla (12 shared papers)Marie D. Ralff (8 shared papers)Yan Zhou (3 shared papers)Lanlan Zhou (5 shared papers)Kerry S. Campbell (2 shared papers)Varun V. Prabhu (4 shared papers)
- Journals
- Cancer Research (6 papers)Oncotarget (4 papers)Molecular Cancer Research (1 paper)Scientific Reports (1 paper)Neoplasia (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Avital Lev
19 papers receiving 384 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 110
- Oncology 182
- Molecular Biology 215
- Cell Biology 51
- Biotechnology 22
Countries citing papers authored by Avital Lev
This map shows the geographic impact of Avital Lev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avital Lev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avital Lev more than expected).
Fields of papers citing papers by Avital Lev
This network shows the impact of papers produced by Avital Lev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avital Lev. The network helps show where Avital Lev may publish in the future.
Co-authors
The 25 scholars most cited alongside Avital Lev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 96 | |
| 2 | 2017 | 56 | |
| 3 | 2017 | 44 | |
| 4 | 2017 | 37 | |
| 5 | 2017 | 30 | |
| 6 | 2018 | 22 | |
| 7 | 2017 | 21 | |
| 8 | 2021 | 17 | |
| 9 | 2020 | 17 | |
| 10 | 2017 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 9 | |
| 13 | 2019 | 3 | |
| 14 | miR-3132 upregulates surface TRAIL to induce apoptotic cell death in cancer cells. | 2022 | 2 |
| 15 | Cell cycle inhibition in human BE-13 T cell leukemia cells by haptoglobin-related (HPR) antisense cDNA. | 1998 | 1 |
| 16 | 2017 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2018 | 0 |
About Avital Lev
Avital Lev is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 20 papers that have together received 386 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cancer therapeutics and mechanisms (3 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (3 papers), Cell death mechanisms and regulation (3 papers), Pancreatic function and diabetes (2 papers), Genetic factors in colorectal cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (110 citations), Oncology (182 citations), Molecular Biology (215 citations), Cell Biology (51 citations) and Biotechnology (22 citations). Avital Lev has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Wafik S. El‐Deiry, David T. Dicker, Amriti R. Lulla, Marie D. Ralff, Yan Zhou, Lanlan Zhou, Kerry S. Campbell, Varun V. Prabhu, Cyril H. Benes and Michael Slifker. Their work appears in journals such as Cancer Research, Oncotarget, Molecular Cancer Research, Scientific Reports and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.